李云春

All filings by 李云春 on record concern 沃森生物, in the capacity of chief executive. In total, 2 filings cover trades dated from 2 June 2021 to 13 January 2022.

The open-market record consists of 2 sales worth €48.0M, with no purchase. 2022 to date brings no purchases and 1 sale.

The latest filing, published on 13 January 2022, reports an open-market sale of €25.3M in 沃森生物. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.